Evolving disparities in the epidemiology of oral cavity and oropharyngeal cancers

Cancer Causes and Control

Volumn 28, Issue 6, 2017, Pages 635-645

  Javadi, Pardis ^a   Sharma, Arun ^a   Zahnd, Whitney E ^a   Jenkins, Wiley D ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer epidemiology; Gender disparities; Head and neck cancers; HPV associated cancers; Human papillomavirus; Oropharyngeal cancer

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CONTROLLED STUDY; FEMALE; GEOGRAPHY; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; RACE; RURAL AREA; SEXUALLY TRANSMITTED DISEASE; UNITED STATES; INCIDENCE; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REGISTER; SEX DIFFERENCE; VIROLOGY;

FEMALE; HUMANS; INCIDENCE; MALE; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REGISTRIES; SEX FACTORS;

EID: 85017148055     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-017-0889-8     Document Type: Article

References (38)

1. Chaturvedi AK, Engels EA, Pfeiffer RM et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32):4294–4301. doi:10.1200/JCO.2011.36.4596
2. National Institutes of Health, National Cancer Institute (2016) HPV and Cancer. Available at: http://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-fact-sheet#q7. Accessed 4 Jan 2016
3. Cole L, Polfus L, Peters ES (2012) Examining the incidence of human papillomavirus-associated head and neck cancers by race and ethnicity in the U.S., 1995–2005. PLoS ONE 7(3):e32657. doi:10.1371/journal.pone.0032657
4. Simard EP, Ward EM, Seigel R, Jemal A (2012) Cancers with increasing trends in the United States: 1999 through 2008. CA Cancer J Clin 62(2):118–128
5. Gillison ML, Broutian T, Pickard RK et al (2012) Prevalence of oral HPV infection in the United States, 2009–2010. JAMA 307(7):693–703. doi:10.1001/jama.2012.101.
6. Zhang H, Dziegielewski PT, Jean Nguyen TT et al (2015) The effects of geography on survival in patients with oral cavity squamous cell carcinoma. Oral Oncol 51(6):578–585. doi:10.1016/j.oraloncology.2015.03.012
7. Chesson HW, Dunne EF, Hariri S, Markowitz LE (2014) The estimated lifetime probability of acquiring human papillomavirus in the United States. Sex Transm Dis 41:660–664
8. Deschler DG, Richmon JD, Khariwala SS, Ferris RL, Wang MB (2014) The “new” head and neck cancer patient-young, nonsmoker, nondrinker, and HPV positive: evaluation. Otolaryngol Head Neck Surg 151(3):375–380. doi:10.1177/0194599814538605
9. Jayaprakash V, Reid M, Hatton E et al (2011) Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985–2010. Oral Oncol 47:1048–1054
10. Zaravinos A (2014) An updated overview of HPV-associated head and neck carcinomas. Oncotarget 5:3956–3969
11. Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14(2):467–475
12. Ernster JA, Sciotto CG, O’Brien MM et al (2007) Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope 117:2115–2128
13. Shin A, Jung YS, Jung KW, Kim K, Ryu J, Won YJ (2013) Trends of human papillomavirus-related head and neck cancers in Korea: National cancer registry data. Laryngoscope 123:E30–E37
14. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML (2008) Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26(4):612–619. doi:10.1200/JCO.2007.14.1713
15. Jemal A, Simard EP, Dorell C et al (2013) Annual Report to the Nation on the Status of Cancer, 1975–2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 105(3):175–201. doi:10.1093/jnci/djs491
16. Chaturvedi AK, Anderson WF et al (2013) Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Onco 31:4550–4559
17. Jamal A, Homa DM, O’Connor E, Babb SD, Caraballo RS, Singh T, Hu SS, King BA (2015) Current cigarette smoking among adults—United States, 2005–2014. MMWR Morb Mortal Wkly Rep 64(44):1233–1240. doi:10.15585/mmwr.mm6444a2
18. Dawson DA, Goldstein RB, Saha TD, Grant BF (2015) Changes in alcohol consumption: United States, 2001–2002 to 2012–2013. Drug Alcohol Depend 148:56–61. doi:10.1016/j.drugalcdep.2014.12.016
19. Nguyen NP, Nguyen LM, Thomas S, Hong-Ly B, Chi A, Vos P, Karlsson U, Vinh-Hung V; International Geriatric Radiation Oncology Group (2016) Oral sex and oropharyngeal cancer: the role of the primary care physicians. Medicine 95(28):e4228. doi:10.1097/MD.0000000000004228
20. D’Souza G, Cullen K, Bowie J, Thorpe R, Fakhry C (2014) Differences in oral sexual behaviors by gender, age, and race explain observed differences in prevalence of oral human papillomavirus infection. PLoS ONE 9(1):e86023. doi:10.1371/journal.pone.0086023
21. Fakery C, Westra WH, Li S et al (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261–269
22. Ang KK, Harris J, Wheeler R et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24–35
23. Benard VB, Johnson CJ, Thompson TD, Roland KB, Lin SM, Cokkinides V, Tangka F, Hawkins NA, Lawson H, Weir HK (2008) Examining the association between socioeconomic status and potential human papilloma virus-associated cancers. Cancer 113(10 Suppl):2910–2918
24. Surveillance, Epidemiology, End Results (SEER) Program (http://www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Research Data, Nov 2014 Sub (1973–2012) < Katrina/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969–2013 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission
25. Surveillance, Epidemiology, End Results (SEER) Program (http://www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data, Nov 2014 Sub (1973–2012) < Katrina/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969–2013 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission
26. United States Department of Agriculture (2016) Rural-urban continuum codes. Available at http://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx. Accessed 11 Jan 2016
27. National Cancer Institute (2016) County attributes. Available at http://seer.cancer.gov/seerstat/variables/countyattribs/ Accessed 11 Jan 2016
28. Markowitz LE, Hariri S, Lin C, Dunne EF, Steinau M, McQuillan G, Unger ER (2013) Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010. J Infect Dis 208(3):385–393. doi:10.1093/infdis/jit192
29. Thompson EL, Vamos CA, Vázquez-Otero C, Logan R, Griner S, Daley EM (2016) Trends and predictors of HPV vaccination among U.S. College women and men. Prev Med 86:92–98. doi:10.1016/j.ypmed.2016.02.003
30. Weatherspoon DJ, Chattopadhyay A, Boroumand S, Garcia I (2015) Oral cavity and oropharyngeal cancer incidence trends and disparities in the United States: 2000–2010. Cancer Epidemiol 39(4):497–504
31. National Cancer Institute Number of Persons by Race and Hispanic Ethnicity for SEER Participants (2010 Census Data) Available at http://seer.cancer.gov/registries/data.html. Accessed 8 Mar 2016
32. National Cancer Institute (2016) Oral Cavity and Oropharyngeal Cancer Screening (PDQ®)–Patient Version. Available at: http://www.cancer.gov/types/head-and-neck/patient/oral-screening-pdq#section/_24. Accessed 3 Aug 2016
33. Steinau M, Saraiya M, Goodman MT et al (2014) Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States. Emerg Infect Dis 20(5):822–828. doi:10.3201/eid2005.131311
34. Curtis CR, Dorell C, Yankey D et al (2014) National human papillomavirus vaccination coverage among adolescents aged 13–17 years-National Immunization Survey--teen, United States, 2011. MMWR Suppl 63(2):61–70
35. Beavis AL, Levinson KL (2016) Preventing cervical cancer in the United States: barriers and resolutions for hpv vaccination. Front Oncol 6:19. doi:10.3389/fonc.2016.00019
36. Henry KA, Stroup AM, Warner EL, Kepka D (2016) Geographic factors and human papillomavirus (hpv) vaccination initiation among adolescent girls in the United States. Cancer Epidemiol Biomarkers Prev 25(2):309–317. doi:10.1158/1055-9965.EPI-15-0658
37. Ortiz M, Torres M, Muñoz L et al (2006) Oncogenic human papillomavirus (HPV) type distribution and HPV type 16 E6 variants in two Spanish population groups with different levels of HPV infection risk. J Clin Microbiol 44(4):1428–1434
38. Muñoz N, Bosch FX, de Sanjosé S et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6):518–527